Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 905463, 12 pages
http://dx.doi.org/10.1155/2014/905463
Research Article

Increased Expression of Chitinase 3-Like 1 in Aorta of Patients with Atherosclerosis and Suppression of Atherosclerosis in Apolipoprotein E-Knockout Mice by Chitinase 3-Like 1 Gene Silencing

1Department of Cardiology, Qianfoshan Hospital, Shandong University, 16766 Jingshi Road, Jinan 250014, China
2Department of Cardiology, Shandong University of Traditional Chinese Medicine, Jinan 250355, China

Received 2 July 2013; Revised 27 November 2013; Accepted 23 January 2014; Published 4 March 2014

Academic Editor: Claudia Monaco

Copyright © 2014 Zushun Gong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Nakashima, E. W. Raines, A. S. Plump, J. L. Breslow, and R. Ross, “Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 5, pp. 842–851, 1998. View at Google Scholar · View at Scopus
  3. C. N. Rathcke and H. Vestergaard, “YKL-40—an emerging biomarker in cardiovascular disease and diabetes,” Cardiovascular Diabetology, vol. 8, article 61, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. C. G. Lee, C. A. Da Silva, C. S. Dela Cruz et al., “Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury,” Annual Review of Physiology, vol. 73, pp. 479–501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. L. Chupp, C. G. Lee, N. Jarjour et al., “A chitinase-like protein in the lung and circulation of patients with severe asthma,” The New England Journal of Medicine, vol. 357, no. 20, pp. 2016–2027, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. W. H. Ma, X. L. Wang, Y. M. Du et al., “Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension,” BMC Cardiovascular Disorders, vol. 12, no. 35, 2012. View at Publisher · View at Google Scholar
  7. C. N. Rathcke, F. Persson, L. Tarnow, P. Rossing, and H. Vestergaard, “YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria,” Diabetes Care, vol. 32, no. 2, pp. 323–328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. K. Røndbjerg, E. Omerovic, and H. Vestergaard, “YKL-40 levels are independently associated with albuminuria in type 2 diabetes,” Cardiovascular Diabetology, vol. 10, article 54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Kyrgios, A. Galli-Tsinopoulou, C. Stylianou, E. Papakonstantinou, M. Arvanitidou, and A.-B. Haidich, “Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children,” Metabolism, vol. 61, no. 4, pp. 562–568, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kucur, F. K. Isman, B. Karadag, V. A. Vural, and S. Tavsanoglu, “Serum YKL-40 levels in patients with coronary artery disease,” Coronary Artery Disease, vol. 18, no. 5, pp. 391–396, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. E. Michelsen, C. N. Rathcke, M. Skjelland et al., “Increased YKL-40 expression in patients with carotid atherosclerosis,” Atherosclerosis, vol. 211, no. 2, pp. 589–595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Batinic, C. Höbaus, M. Grujicic et al., “YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes,” Atherosclerosis, vol. 222, no. 2, pp. 557–563, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. B. Mathiasen, M. J. Harutyunyan, E. Jrgensen et al., “Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 71, no. 5, pp. 439–447, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. H. von der Thüsen, T. J. C. van Berkel, and E. A. L. Biessen, “Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice,” Circulation, vol. 103, no. 8, pp. 1164–1170, 2001. View at Google Scholar · View at Scopus
  15. J. H. von der Thüsen, B. J. M. van Vlijmen, R. C. Hoeben et al., “Induction of atherosclerotic plaque rupture in apolipoprotein E−/− mice after adenovirus-mediated transfer of p53,” Circulation, vol. 105, no. 17, pp. 2064–2070, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Burger-Kentischer, H. Göbel, R. Kleemann et al., “Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF),” Atherosclerosis, vol. 184, no. 1, pp. 28–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Zhang, M. Kawanishi, K. Miyake et al., “Association between YKL-40 and adult primary astrocytoma,” Cancer, vol. 116, no. 11, pp. 2688–2697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Faibish, R. Francescone, B. Bentley, W. Yan, and R. Shao, “A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers,” Molecular Cancer Therapeutics, vol. 10, no. 5, pp. 742–751, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. N. Rathcke and H. Vestergaard, “YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis,” Inflammation Research, vol. 55, no. 6, pp. 221–227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. R. G. Boot, T. A. E. Van Achterberg, B. E. Van Aken et al., “Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 3, pp. 687–694, 1999. View at Google Scholar · View at Scopus
  21. H. Matta, B. Hozayev, R. Tomar, P. Chugh, and P. M. Chaudhary, “Use of lentiviral vectors for delivery of small interfering RNA,” Cancer Biology and Therapy, vol. 2, no. 2, pp. 206–210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. K. V. Morris and J. J. Rossi, “Lentiviral-mediated delivery of siRNAs for antiviral therapy,” Gene Therapy, vol. 13, no. 6, pp. 553–558, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Kawada, H. Seno, K. Kanda et al., “Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer,” Oncogene, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-C. Chen, V. Llado, K. Eurich, H. T. Tran, and E. Mizoguchi, “Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells,” Clinical Immunology, vol. 140, no. 3, pp. 268–275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Ozeren, M. Aydin, M. Tokac et al., “Levels of serum IL-1β, IL-2, IL-8 and tumor necrosis factor-α in patients with unstable angina pectoris,” Mediators of Inflammation, vol. 12, no. 6, pp. 361–365, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-Z. Kong, X. Yu, J.-J. Tang et al., “Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques,” Atherosclerosis, vol. 178, no. 1, pp. 207–215, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. C. W. Moehle, C. M. Bhamidipati, M. R. Alexander et al., “Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation,” Journal of Thoracic and Cardiovascular Surgery, vol. 142, no. 6, pp. 1567–1574, 2011. View at Publisher · View at Google Scholar · View at Scopus